Clinical Trial Update: A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CLS2901C for osteoarthritis of the knee is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• CLS2901C

Snippet

Sponsor: CellSeed Inc. | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: RECRUITING